Background: Leukoencephalopathy with brain stem and spinal cord involvement and
INTRODUCTION
"Leukoencephalopathy with brain stem and spinal cord involvement and high brain lactate" (LBSL) is a recently described white matter disease with distinct findings in magnetic resonance imaging (MRI) and spectroscopy [1, 2] . The disease manifests during childhood or young adulthood [3, 4] , progresses slowly and affects the pyramidal tract, cerebellum and spinal cord. Brain MRI findings are uniquehemispheric patchy or confluent white matter changes with involvement of specific brain stem and spinal cord tracts -and, in the majority of cases, proton magnetic resonance spectroscopy ( 1 H-MRS) shows elevated lactate in abnormal brain white matter, whereas serum and cerebrospinal fluid lactate and other laboratory investigations are normal. LBSL was shown to be caused by mutations in DARS2, a mitochondrial aspartyl transfer-RNA synthetase [5] . Scheper et al reported 38 patients from 30 families, with compound heterozygous mutations in the DARS2 gene.
We studied the molecular background of Finnish patients with typical LBSL-findings in MRI and spectroscopy. Furthermore, we studied the role of DARS2 mutations in multiple sclerosis (MS), which is the most common disease affecting the white matter in young adults, and previously suggested as a differential diagnosis for LBSL [6] .
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PATIENTS AND METHODS
Patients and samples
We studied DNA samples of eight patients, four males and four females, with the clinical diagnosis of LBSL, based on typical MRI findings (supplementary 
LBSL DNA analysis
The human chromosome 1 reference assembly sequence, which contains DARS2 genomic sequence (NT_004487) and DARS2 mRNA (NM_018122) were used as Isohanni P et al. 6 reference sequences. Genomic DNA was extracted from peripheral blood samples by using standard procedures. The coding sequence and the intron-exon boundaries of exons 3, 5 and 17 of DARS2 were amplified by polymerase chain reaction (PCR) using previously described primers [5] . For DNA sequence analysis we used the BigDye by PCR and solid-phase minisequencing as described [7] . The primer sequences for c. The complete DARS2 coding sequence and the intron-exon boundaries of those MS patients, who carried either of the two LBSL-associated mutations as heterozygous, were determined. The primer sequences were as in [5] .
Haplotype analysis
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We analyzed five polymorphic dinucleotide/trinucleotide markers flanking the DARS2 gene (D1S2790, D1S1589, D1S218, D1S2691 and D1S416). We added TAATACGACTCACTATAGGGAGA-tag to the 5'tail of forward primer of every marker (tag-forward-primer), as well as the same tag alone with FAM-label (FAM-tagprimer), which was used to label the PCR-product during the amplification. Fragment analysis was performed in ABI3730XL DNA Analyzer (Applied Biosystems) with
GeneScan LIZ-500 size standard, and the data was analyzed with GeneMapper 4.0 software (Applied Biosystems).
Isohanni P et al. Pes cavus Abbreviations: N = normal, nt = not testable, ND = not done, MCV = motor conduction velocities, NCV = nerve conduction velocities, DL = distal latencies, ampl, = amplitudes.
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RESULTS
Clinical manifestations
Patient 3
This 18-year-old boy had healthy parents and an affected elder brother (patient 2).
Pregnancy and birth of the patient were normal. He learned to walk at the age of 10 months and always had good motor skills. At the age of 8 years he had a few nocturnal This 5-year-old boy was born at term to healthy parents. His elder brother is healthy.
At the age of 19 months he was examined because of delayed motor development. He was ataxic and hypotonic. He learned to walk unsupported at the age of 2 years, but Isohanni P et al. 12 fell frequently. Distal spasticity, bilateral Babinski sign and hyperreflexia were evident from the age of 2 years 3 months.
Brain MRI (figure 1 F-J) showed wide-spread white matter abnormalities typical for LBSL in the supratentorial region, with minimal cerebellar and brain stem involvement. Partial hypoplasia of the right cerebellar hemisphere was noted.
At the age of 3.5 years he had a minor trauma after falling from a chair. He did not lose consciousness, but was very tired, floppy and unable to walk for 4 days. Brain MRI, performed 2 weeks after the initial trauma, was unchanged. His walking gradually improved but did not return to the previous level and at present he is able to walk short distances independently. His fine motor skills are appropriate for age, but his speech development is mildly delayed.
Variation in MRI findings
Patients 4, 7 and 8, who had the earliest onset of symptoms, showed the most widespread brain MRI changes. Patient 7 with severe hemispheric changes had only subtle hyperintensity within the cerebellar white matter and lesions in the pyramids, and in addition to typical LBSL findings he had partial hypoplasia of the right cerebellar hemisphere ( figure 1 F-J) . MRS showed high choline with reduced NAA and a high lactate peak. In patient 3, MRI-findings preceded motor symptoms for several years. At the age of 8 years MRI showed abnormalities typical for LBSL [2] , but minor ataxia appeared only 7 years later. MRI at age 18 showed some progression of the posterior fossa lesions, but no further change of the supratentorial white matter ( figure 1 A-E) . MRS showed no lactate and only a minor increase of choline was noted, although a lactate peak had been detected earlier.
DNA analysis of LBSL patients
Isohanni P et al. 13 All eight patients from 7 families had compound heterozygous mutations in DARS2.
All patients had a mutation in the 3'-region of intron 2, a TT deletion and C insertion (c.228-20_21delTTinsC). All patients had a second mutation in exon 5: the seven patients of Finnish origin had a C to T transversion at the splice site of exon 5 (c.492+2T>C), and the patient of Russian origin had a G to T transversion at nucleotide 455 (c.455G>T).
Carrier frequency
We analyzed Finnish control chromosomes for the presence of the identified DARS2 Figure 2 shows the results of the haplotype analysis. The patients shared a common core haplotype of three or four polymorphic markers, extending over a chromosomal region of ~1,4 Mb. However, in some patients the shared haplotype extended to 2,1
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Mb. These haplotypes were previously reported in patients from Europe and North America [5] .
DNA analysis of MS patients
LBSL shows some overlapping clinical and neuroradiological features with MS. As the carrier frequency for the common DARS2 mutation c.228-20_21delTTinsC (p.R76SfsX5) was found to be considerably high (1:95), we tested the frequency of this and the M134_K165del variant in MS patient population. Four heterozygotes were identified in 321 MS families. The c.228-20_21delTTinsC mutation was found in two Isohanni P et al. 14 families, but only once transmitted from the parent to the MS patient. The c.492+2T>C (p.M134_K165del) mutation was found in two MS patients and in one parent (the sample from the putative carrier parent was not available for study to a previous report [5] . This is unusual on the basis of the Finnish carrier frequencies
(1:95 and 1:380), and suggests either that homozygosity for DARS2 mutations is embryonic lethal or manifests as a different, yet unidentified phenotype. We also show considerable variation in clinical symptoms, even in patients with identical mutations, as also seen in some other mitochondrial disorders [8] . This suggests that secondary predisposing / protecting genetic factors may affect the tissue responses to mitochondrial dysfunction and the disease manifestations.
The age of onset of LBSL varied from two to 15 years. Most patients learned to walk at normal age, but their gait remained unsteady, while the performance of some patients improved from initial manifestation. By adolescence, a mixture of upper and lower motor neuron, cerebellar, and dorsal column signs ensued. Most of the reported LBSL patients have become wheelchair-dependent in their teens or twenties [9] , but all of our patients, six already young adults, are still able to walk. It is important to consider LBSL upon in patients with progressive white-matter disease of adolescence.
The white matter changes of LBSL are unique. The specificity of typical MRI pattern is emphasized by the fact that all our patients, whom we had identified by their MRI findings, also carried DARS2 mutations. This kind of symmetrical white matter lesions are unusual for mitochondrial disorders, where focal necrotic or stroke-like lesions, symmetrical deep gray matter lesions and cerebral or cerebellar atrophy are typical
Isohanni P et al. 16 [10] . Axonal neuropathy -in contrast to demyelinating neuropathy found in conjunction with classical leukoencephalopathies -is recognised as an important feature of many mitochondrial disorders [11] . Axonal neuropathy was a common finding in the present series of LBSL patients with DARS2 mutations (Table 1) . This feature was not initially described as part of the syndrome [1] , but has been reported previously in four patients [12, 13] . Axonal neuropathy in LBSL patients is comparable to that of NARP (neuropathy, ataxia and retinitis pigmentosa) and diseases caused by PEO1, POLG1 and MNF2 mutations, suggesting shared mechanisms underlying mitochondrial axonopathies. LBSL should be considered even in adult patients with slowly progressive ataxia and neuropathy.
Our patients were compound heterozygotes for three different DARS2 mutations. All had a intron-2 mutation, the most frequent mutation reported previously [5] , accompanied by a splice site mutation in exon 5. The Finnish patients shared minimally a 2.1 Mb core haplotype with each other, indicating common ancestry.
Perhaps surprisingly, however, as Finland is a genetic isolate, our patients shared a 1-2
Mb haplotype also with previously published Western European, Russian and North American DARS2-chromosomes, which indicated the existence of common, most likely European, ancestors. Similar pan-European ancestry has been found in other mitochondrial neurodegenerative disorders, such as mitochondrial recessive ataxia syndrome (MIRAS) [8, 14] and Friedreich's ataxia [15, 16] . Similar to DARS2 mutations, also MIRAS-associated mtDNA polymerase gamma (POLG1) mutations show high carrier frequency in the population -1:95 and 1:380 for DARS2 and 1:125
for MIRAS W748S mutation in Finland. Ancient haplotypes suggest that these housekeeping genes are not mutational hot-spots, and high carrier frequency suggests that carriership is not disadvantageous for getting progeny. Isohanni P et al. 17 Multiple sclerosis is the most common disorder affecting the white matter of young adults, and it has been mentioned as a differential diagnosis for LBSL [6] . Due to the relatively high carrier frequency of DARS2 mutations, and the lack of homozygotes, we studied patients with MS and their parents to test whether DARS2 mutations would be MS risk factors or whether some LBSL patients were phenocopies of MS.
However, we found a considerably lower number of heterozygote DARS2 carriers in the MS population than in the control population. We conclude that the common DARS2 mutations are not common risk factors for MS.
LBSL, caused by mutations in a gene encoding mitochondrial aspartyl-tRNA synthetase, was the first reported human disease caused by a defect in a nuclear- LBSL is a new disease among mitochondrial ataxias, and in Finland mutations in DARS2 are among the most common causes of childhood-onset leukoencephalopathy.
So far most of the LBSL cases are diagnosed by paediatric neurologists, but since first symptoms can arise in adolescence or young adulthood, it is important also for adult neurologists to recognize this disease. Due to considerably high carrier frequency and the ancient common European origin of these haplotypes, the mutations are likely to be quite common also in other European-derived populations. Italy, and haplotype indicated by dark gray box is the same as in patients from Canada, Russia, Turkey and Eastern Europe [5] .
